SCHEMBL2894041

SCHEMBL2894041

CCNC1CCCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4655477 0.98 KCNH2 (0.38)
Hydrochloric Acid SCHEMBL27843088 0.98 KCNH2 (0.38)
SCHEMBL2892531 0.93
SCHEMBL22563720 0.80
SCHEMBL1952601 0.77 CXCR4 (0.32)
SCHEMBL17641535 0.77
SCHEMBL3644949 0.76
SCHEMBL28931546 0.74 FDPS (0.31)
SCHEMBL28210285 0.74
SCHEMBL12160622 0.74 RAD52 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118488982-A Polyol catalyst for two-component polyurethane systems 阿科玛法国公司 2024-08-13 CN claimed
CN-118488982-A Polyol catalyst for two-component polyurethane systems 阿科玛法国公司 2024-08-13 CN disclosed
US-8614330-B2 Substituted benz-azoles and methods of their use as inhibitors of RAF kinase NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2013-12-24 US disclosed
US-8383624-B2 Pyrrolopyrazine inhibitors of kinases ABBOTT LABORATORIES (US) 2013-02-26 US disclosed
US-20120288501-A1 SUBSTITUTED BENZAZOLES AND METHODS OF THEIR USE AS INHIBITORS OF RAF KINASE NOVARTIS VACCINES AND DIAGNOSTICS, INC. FORMERLY KNOWN AS CHIRON CORPORATION (US) 2012-11-15 US disclosed
US-8299108-B2 for treatment of hematological/hormone-dependent cancer NOVARTIS AG (CH) 2012-10-30 US disclosed
US-20110015172-A1 PYRROLOPYRAZINE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2011-01-20 US disclosed
US-20100227856-A1 NOVEL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2010-09-09 US disclosed
US-20100196368-A1 SUBSTITUTED BENZ-AZOLES AND METHODS OF THEIR USE AS INHIBITORS OF RAF KINASE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2010-08-05 US disclosed
US-7728010-B2 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2010-06-01 US disclosed
US-6426337-B1 ANTIINFLAMMATORY AGENTS SMITHKLINE BEECHAM CORPORATION 2002-07-30 US disclosed
US-20020086850-A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives COX BRIAN (GB) 2002-07-04 US disclosed
WO-2001092232-A1 4-AMINOQUINOLINES AS ANTIINFECTIVE AGENTS UFC LTD. (GB) 2001-12-06 WO disclosed
CN-1246124-A 2- (purin-9-YL) -tetrahydrofuran-3, 4-diol derivatives GLAXO GROUP LTD (GB) 2000-03-01 CN disclosed
EP-0948509-A1 2-(PURIN-9-YL)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES GLAXO GROUP LIMITED (GB) 1999-10-13 EP disclosed
WO-1998028319-A1 2-(PURIN-9-YL)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES GLAXO GROUP LIMITED (GB) 1998-07-02 WO disclosed
EP-0187524-B1 A DIARYL BUTYRIC ACID DERIVATIVE AND THE PRODUCTION PROCESS THEREOF SUNTORY LIMITED (JP) 1992-07-29 EP disclosed
US-4766116-A NERVOUS SYSTEM DISORDERS SUNTORY LIMITED (JP) 1988-08-23 US disclosed
EP-0187524-A2 A diaryl butyric acid derivative and the production process thereof SUNTORY LIMITED (JP) 1986-07-16 EP disclosed
US-4288592-A Process for preparing amides by reaction in presence of molecular sieve AMERICAN CYANAMID COMPANY (US) 1981-09-08 US disclosed